SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-10-000064
Filing Date
2010-01-20
Accepted
2010-01-20 15:43:08
Documents
6
Period of Report
2010-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TETRAGENEX PHARMACEUTICALS, INC. FORM 8-K JANUARY 19, 2010 ttrx8k20100119.htm 8-K 34581
2 SETTLEMENT AGREEMENT, DATED JANUARY 11, 2010 ttrx8k20100119ex99-1.htm EX-99.1 3098
3 pg1.jpg GRAPHIC 112493
4 pg2.jpg GRAPHIC 98248
5 pg3.jpg GRAPHIC 101705
6 pg4.jpg GRAPHIC 27806
  Complete submission text file 0001096906-10-000064.txt   508441
Mailing Address 560 SYLVAN AVE 3RD FLOOR ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE 3RD FLOOR ENGLEWOOD CLIFFS NJ 07632 (201) 408-5335
TETRAGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0001362659 (see all company filings)

IRS No.: 223781895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52292 | Film No.: 10536220
SIC: 2834 Pharmaceutical Preparations